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The hemolytic plaque assay (1)  for the detection  and study of antibody-secreting 
cells has been a  fundamental  tool in the armamentarium of cellular immunologists 
since  its  introduction  almost  two  decades  ago.  The  basic Jerne  technique  detects 
individual  cells secreting  antibody of a  particular  specificity.  A  recently  described 
modification of this assay permits the detection of all immunoglobulin-secreting cells, 
regardless of their specificity (2).  The method employs sheep erythrocytes (SRBC)1 
coated  with  staphylococcal  protein  A  in  a  plaquing  medium  which  also  contains 
rabbit anti-mouse Ig, guinea pig complement, and Ig-secreting mouse plasmacytoma 
cells. Plaques developed around a  fraction of the cells, presumably as a consequence 
of Ig-anti-Ig complexes binding to the protein A-coated RBC and fixing complement. 
A  compelling feature of this  procedure  is  that  it  permits  the  detection  of any cell 
secreting a  product for which an antiserum is available, provided that the antibody 
can bind to protein A  and can fix complement. 
Because splenic T  cells activated with Concanavalin A release a variety of products, 
including  soluble helper and suppressor factors  (3),  it seemed  feasible that  antisera 
could  be generated  against  these products  and  used  to detect  T  cells secreting the 
products in a similar plaque assay. This communication describes the development of 
such  an  assay,  provides  conclusive  evidence  that  the  plaque-forming  cells  are  T 
lymphocytes and presents quantitative and kinetic data on the T-cell responses which 
are detected. It will be apparent that this plaque assay detects activated T  cells with 
a  facility comparable to that of the classical Jerne technique for B cells. 
Materials and Methods 
Mice.  BDF1  and BALB/c, matched for age and sex, were used through these experiments 
and were purchased  from Simonson Labs, Gilroy, Calif.,  or were kindly provided by other 
investigators. 
Mitogens.  Concanavalin  A  (Con  A)  was  obtained  as  a  lyophilized  powder  from  Miles 
Laboratories Inc., Miles Research Products, Elkhart, Ind. Lipopolysaccharide from Escherichia 
coli (LPS) was obtained from Sigma Chemical Co., St. Louis, Mo. Phytohemagglutinin M was 
purchased from Difco Laboratories, Detroit, Mich. 
Culture Conditions.  Cells  were  cultured  in  Cluster  24  tissue  culture  plates  (Costar  Data 
Packaging,  Cambridge,  Mass.)  at  a  concentration  of  1.0  ×  107  sj~leen cells/ml  in  0.5-ml 
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cultures. Cultures were incubated in plastic boxes in an atmosphere of 10% CO2, 83% Nz, and 
7% Oz. 
Medium.  The  medium  used  in  these  experiments was  RPMI-1640  supplemented with 
glutamine, gentamicin, and 5% fetal calf serum. 
Preparation of Culture Supernates.  Spleen cells were cultured for 48 h in serum-free medium in 
the presence of 1 #g of Con A. Thereafter, cells were removed by centrifugation and Con A was 
eliminated by absorbing the supernatant fluids with Sephadex G-50 (Pharmacia Fine Chemi- 
cals, Div. of Pharmacia Inc., Piscataway, N. J.) at 4°C at a ratio of 1 ml hydrated Sephadex to 
1 ml fluid (4). Supernates were concentrated to 0.2 of the initial volume (in dialysis bags)  by 
perevaporation in a stream of air. 
Developing Antisera.  Rabbits were given four subcutaneous injections at  10-d intervals of 1 
ml of crude Con A-induced supernate in complete Freund's adjuvant (Difco Laboratories). The 
animals were bled after each boost and sera was stored at -70°C. For some experiments, the 
IgG fraction of rabbit antiserum was prepared by batch fractionation with DEAE-cellulose. 
Absorption of antiserum to remove antibodies directed against mouse immunoglobulins  was 
carried  out  using an  immunoadsorbent consisting of affinity-purified mouse Ig coupled to 
Sepharose 4B. Antiserum and adsorbent were mixed in equal volumes and incubated overnight 
at 4°C. The absorbed antiserum was recovered by centrifugation. 
Coupling of Protein A to SRBC.  Staphylococcal protein A (Sigma Chemical Co.) was coupled 
to SRBC as described by Gronowicz et al. (2). 
Plaque Assay.  Cells were harvested and washed twice in cold balanced saline solution (BSS) 
and adjusted to the desired concentration. One part of prewarmed Eagle's minimal essential 
medium (Grand Island Biological Co., Grand Island, N. Y.) containing 2.0 mg/ml of DEAE- 
dextran (Pharmacia, Uppsala, Sweden) was  added to an equal volume of 1.4% agar (Difco 
Laboratories), in HzO. Two-ml aliquots of the mixture were put in 5-ml plastic tubes at 46°C 
in a water bath. Thereafter, 0.1 ml of the protein A-coated SRBC diluted 1:4 in BSS, 0.05 ml 
of the lymphocyte suspension, and 0.1  ml of developing serum (appropriately diluted) were 
added to each tube. The ingredients were mixed and spread on 9-cm plastic Petri dishes (Falcon 
Labware,  Div. of Becton, Dickinson, & Co., Oxnard, Calif.) which were then incubated at 
37°C. 2 ml of guinea pig complement, diluted 1/50, were added to each dish after 1 or 18 h. 
Plates were incubated for another hour at 37°C. When lymphocytes were stained for Thy-1 
antigen, 0.1  ml of a  mixture containing agar,  lymphocytes, developing serum, SRBC,  and 
complement was put as a drop on a microscope slide and a cover slide immediately put on the 
drop.  This  procedure  gave  a  thin  layer  of  agar  which  facilitated  the  scoring of stained 
lymphocytes in the middle of plaques. Plaque-forming cells were counted using indirect light. 
Cell Fractionation.  B cells were removed from spleen cell suspensions as previously described 
by allowing the spleen cell suspensions to settle onto plastic Petri plates precoated with affinity- 
purified rabbit anti-mouse Ig (5, 6). This procedure routinely yielded T-cell preparations that 
were >95% pure as judged by anti-Thy-  1 cytotoxicity and by staining with fluorescent anti-Ig. 
Indirect Fluorescence Assay for  Thy-1.  (Fab')2  fragments from anti-Thy-1 antibody were pre- 
pared by standard procedures and substituted with DNP groups to a level which did not curtail 
antigen binding. The DNP-(Fab')z conjugates were reacted for 30 min at 4°C with spleen cells. 
The cells were washed and then treated with fluorescein-conjugated  (Fab')2 fragments of rabbit 
anti-DNP antibody prepared  against  2,4-dinitrophenyl (DNP)-ovalbumin conjugates.  The 
immunoglobulin  reagents used in this procedure were (Fab')z fragments to avoid reactions with 
Fc receptors on lymphoid cells. 
Rosette Formation.  Spleen cells from BDF1 mice (2 ×  107/ml) were reacted at 4°C for 30 min 
with  1 ml of anti-supernate antiserum diluted 1:20. Thereafter, cells were washed twice and 
resuspended in  1.0 ml, of BSS.  1 ml of a  0.2% suspension of aseptically coupled protein A- 
SRBC was added to the lymphocyte suspension and the mixture was incubated for  15 rain at 
4°C. Cells were then centrifuged at  1,000 rpm for  1 min and gently resuspended in 3 ml of 
RPMI-1640  medium.  Rosetting and  nonrosetting cells  were  separated  by  Ficoll-Isopaque 
(Sigma Chemical Co., St.  Louis, Mo.)  density gradient and the erythrocytes were lysed  with 
ammonium chloride. 
T-Cell Long-term Cultures.  Spleen cells from BDF1 mice were fractionated on anti-mouse Ig- 
coated plastic Petri dishes. The nonadherent population (<5% Ig positive)  was cultured for 48 PRIMI, LEWIS, AND GOODMAN  989 
h at a density of 107 eells/ml  in the presence of 2 or 20/~g/ml  of Con A. Thereafter,  cells were 
harvested and recultured  at 5 ×  105/ml in RPMI-1640 medium containing 2-mercaptoethanol 
(5  X  10  -s M),  10% fetal calf serum, glutamine (2 mM), gentamicin,  and 2 or 20 #g/ml of Con 
A.  At 3-d intervals,  each well (containing  0.5 ml of cell suspension)  received 0.1  ml Con A- 
induced  culture  supernate  concentrated  fivefold.  Cell growth  was  monitored  in  a  Burker 
hemocytometer (American Optical Corp.,  Buffalo, N. Y.) and cells were resuspended  at 5  × 
105/ml every 5 d. 
Induction of Cytotoxic Cells.  Allogenically sensitized cytotoxic cells from BALB/c mice (against 
L929 cells) were kindly provided  by Dr. W. Rosenau (Department  of Pathology and Cancer 
Research Institute,  University of California,  San Francisco). They were prepared according to 
a modification  of the method of Rosenau  and Moon (7). 
Anti-Thy 1 and Anti-Ly 2.2 Treatment.  Spleen cells from BDFI mice were treated for 30 min 
at 4°C either  with anti-mouse  Thy  1 antiserum  generated  in  rabbits  using  mouse brain as 
antigen and rendered  specific as described  previously  (8)  or with  a  monoclonal  anti-Ly 2.2 
serum  (from  Dr.  U.  Hammerling,  Sloan-Kettering  Institute,  N.  Y.). Thereafter,  cells were 
washed in BSS and treated with a selected source of complement for another 30 min at 37°C. 
Dead cells and erythrocytes  were separated  by Ficoll-Isopaque density gradient  centrifugation. 
Results 
Production  of Antisera  against  Con-A-induced  Culture  Supernates.  Each  of two  rabbits 
injected  four  times  subcutaneously  with  1.0  ml  of fivefold  concentrated  Con  A 
supernate produced antiserum which developed plaques by spleen cells  cultured for 
48 h in the presence of 10 ~g/ml of Con A  (Table I, Fig.  1). The two sera differed in 
potency and plaque  formation by Con A-activated lymphocytes was dependent  on 
the  concentration  of the  developing serum.  Omission  of either  the  anti-supernate 
serum or complement from the assay abrogated the appearance of plaques. Negative 
results were also obtained when serum  from normal rabbits was substituted  for the 
anti-supernatant serum, demonstrating the dependence of plaque formation on anti- 
supernatant  antibody. Unless otherwise stated,  in the experiments described below, 
serum from rabbit 2 at a  dilution of 1:4 was routinely used. 
Response to Selective Mitogens.  The effect of  selective T-cell mitogens on the induction 
of plaque-forming cells  (PFC)  was investigated.  The dose-response curves of spleen 
cells  cultured  for  24  h  in  the  presence  of various  concentrations  of Con  A  and 
phytohemagglutinin (PHA) revealed that both mitogens induced strong responses at 
sufficiently high  concentrations  (Fig.  2  A).  In  these  experiments,  complement was 
added to the plates after 1 h of incubation. It was considered of interest to determine 
if  longer  plaquing  times  would  alter  the  magnitude  or  quality  of the  response, 
Accordingly, the experiments were repeated except that complement was added after 
18 h of incubation (Fig.  2 B). It is apparent that the longer plaquing time resulted in 
a dramatic increase in the number of PFC and in a shift in the response to lower doses 
of mitogen. The data  indicate  that  high concentrations of mitogen induce a  rapid 
release of the product(s)  being detected, whereas lower concentrations induce more 
gradual secretion by a  larger proportion of cells.  Consequently, in order to achieve 
optimal sensitivity all subsequent experiments were performed using an  18-h plaque 
assay, 
Kinetic analysis of these mitogen responses disclosed peak PFC values after  1-2 d 
of culture (Fig.  3). On the other hand, the selective B-cell mitogen lipopolysaccharide 
(LPS) induced negligible PFC responses over the entire 5-d period studied. The slight 
enhancement seen on days 2 and 3 is likely a  result of a  polyclonally induced B-cell 990  T-CELL  PLAQUE ASSAY 
TABLE  I 
Anti-Con A Supernatant Activity of Rabbit Serum Measured by Protein A Plaque Assay 
Rabbit*  No. of in-  PFC/culture 
jections  Serum dilutions 
1/1  1/2  1/3  1/4  1/5  1/6  1/7 
1  0  0  0  0  0  0  0 
2  0  0  0  0  0  0  0 
3  0  0  0  0  0  0  0 
4  4,160  5,640 ::l: 196  1,224  +  68  0  0  0  0 
:t:  124 
1  0  0  0  0  0  0  0 
2  0  0  0  0  0  0  0 
3  0  3,244  ::tz 60  2,860  +  120  0  0  0  0 
4  0  3,600  +  136  4,800 +  600  5,600 +  312  2,080  ::t: 80 
* Rabbits received the indicated injections of 1.0 ml of concentrated  Con A supernate  at  10-d intervals. 
Serum was always collected 7 d after each injection. Activity was measured by PFC response of spleen 
cells cultured for 48 h in the presence of 10/lg/ml of Con A. 
anti-SRBC response, which always occurs after exposure to LPS  (8). These findings 
minimize the likelihood that the PFC in this assay are B  cells. 
Nature of the PFC.  The most immediate priority in this study was to establish the 
identity of the PFC. For this purpose, the following experiments were carried out. 
(a)  Cultured  cells were assayed for the Thy-1  antigen by the indirect immunoflu- 
orescent  technique  described  in  Materials  and  Methods.  The  cells  were  plaqued 
immediately after staining. About 50%  of the lymphocytes in the centers of plaques 
stained strongly for Thy-1.  Because the plaque assay is carried out  under conditions 
which lead to capping and internalization of antigen-antibody complexes, this figure 
represents a  minimum value for Thy-1-positive PFC. 
(b)  Spleen cells were cultured with  l0/~g of Con A  for 24 h,  at which  point they 
were treated with anti-Thy-1 serum and complement, with a  monoclonal anti-Ly-2.2 
serum  and  complement,  or  with  complement  alone.  Dead  cells were  removed  by 
Ficoll-Isopaque  density  gradient  centrifugation  before  plaquing  to  minimize  the 
detection of products released by such cells. Treatment with anti-Thy-1 or with anti- 
Ly-2.2 virtually eliminated PFC (>95% depletion; Table II). On the other hand, these 
reagents  had  no significant effect on  the polyclonal response of spleen cells to  LPS 
(data not shown). 
(c) Spleen cells were depleted of B cells by adherence to plastic surfaces coated with 
affinity-purified rabbit anti-mouse Ig antibody. The nonadherent  population  (<5% 
Ig-positive by fluorescence)  was  then  cultured  for  24  h  with  10  ~g/ml  Con  A  and 
assayed  for  PFC.  Removal  of B  cells  doubled  the  proportion  of PFC  (Table  II), 
providing additional evidence that at least the vast majority of PFC in the assay are 
T  cells. 
(d)  Although  the  inability to detect  PFC  responses after polyclonal activation of 
spleen cells with LPS (Fig. 3) provided persuasive evidence that this plaque assay did 
not  detect  immunoglobulin-secreting cells, to conclusively eliminate that  possibility 
the anti°supernatant serum was absorbed with a polyvalent mouse Ig immunoadsorb- 
ent. This adsorbent, which was very effective for the removal and purification of anti- PRIMI, LEWIS, AND GOODMAN  991 
Fro.  l.  Plaques  formed by spleen cells from BDFI mice cultured for 24 h with 10 #g/ml of Con A. 
Complement was added after 1 h of incubation in the plaquing medium. 
mouse Ig antibodies (6),  had no effect whatsoever on the developing capacity of the 
antiserum in the PFC assay (Fig. 4), providing conclusive evidence that Ig-secreting 
cells were not being detected. 
The  above  findings,  combined  with  the  selective  activation  of  PFC  by  T-cell 
mitogens, convincingly attest to the T-cell nature of PFC detected by this assay. 
PFC in  Long-term Cultures of T  Cells.  Recent  advances  in  cell  culture  techniques 
have made it possible to selectively grow T  or B cells  for extended periods of time (9). 
Taking advantage of the new methodologies, fractionated T  cells were maintained in 
culture for 10 d in the continuous presence of 2 or 20 #g of Con A and T  cell growth 
factor  (provided  by Con  A-induced  culture  supernate).  The  method  permits  only 
those cells which respond to Con A to survive and divide. About 2% of T  cells which 
had grown for I0 d in the continuous presence of 2 or 20 #g of Con A formed plaques 
(Fig.  5).  Again,  it  was  found  that  addition  of complement  after  1 h  of plaquing 
detected only those cells  activated by the high dose of mitogen, whereas low doses of 
mitogen induced much slower secretion detectable after the longer plaquing period. 992 
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FIc.  2.  Spleen cells from BDF1 mice were cultured for 24 h with the indicated doses of Con A 
(O) or PHA ('), after which the PFC responses were assayed. Complement  was added either 1 h 
(A) or t8 h (B) after plaquing. 
PFC  Detection  In  a  Population  of Cytotoxic  Cells.  It  was  of  interest  to  investigate 
whether  the  anti-supernatant  antiserum  could  detect  ceils with  specific functional 
activity. For these studies, murine spleen cells were sensitized to alloantigens according 
to  the  method  of Rosenau  and  Moon  (7).  BALB/c  mice  received one  intrasplenic 
injection  of 5  ×  106  L929  cells.  1  w  later,  spleens  were  removed  and  cells  were 
incubated  for  18  h  on  a  monolayer  of  L929  cells.  Thereafter,  nonadherent  and 
adherent  (cytotoxic)  cells were  removed  and  tested  for  PFC.  As seen  in  Fig.  6,  the 
adherent cells plaqued with an efficiency of ~  10%, whereas significant responses were 
not made by the nonadherent  or control populations. It is also noteworthy that  the 
adherent  population  was  >95%  Thy-l-positive  by  fluorescent  microscopy.  These 
results indicate that  the anti-supernatant  antiserum  detects products released by T 
cells activated by aUogeneic targets, which are most likely cytotoxic T  cells. 
Anti-supernatant Antibodies Selectively Bind to T Cells.  The capacity ofanti-supernatant 
antibody to bind to lymphocytes was investigated. Unfractionated or B-cell-depleted 
spleen  cells  were  sequentially  reacted  with  the  IgG  fraction  of  the  anti-Con  A 
supernatant  serum  and  fluorescent protein A. After this treatment,  ----50% of spleen 
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Fro.  3.  Spleen cells of BDF1 mice were cultured for 5 d with nothing (1),  100 #g/ml LPS (I-q), 10 
#g/ml Con A (A), or PHA (O). PFC responses were assayed each day. 
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TAnLE  II 
Effect of Various Treatments  on Plaque-forming  Cells 
Mitogen  Treatment  PFC/10  e Cells 
--  --  1,800 +  124 
Con A  --  14,400 4- 284 
Con A  B-depleted  29,700  +  697 
Con A  Complement  11,720 +  252 
Con A  a-Thy-1  +  C  340  +  55 
Con A  a-Ly-2.2 +  C  480  +  62 
Spleen cells from BDFI mice were cultured for 48 h in the presence of 10 #g of 
Con A. Thereafter, cells were harvested, treated as indicated, and dead cells 
were removed by Ficoll-Hypaque density gradient centrifugation. 
findings,  therefore,  indicate  that  the antiserum  detects  products  which  are expressed 
on  the  surface  of  a  majority  of  T  cells.  In  a  subsequent  series  of  experiments, 
lymphocytes  which  bound  the  anti-Con  A  supernatant  antibody  were  isolated  by 
rosetting with SRBC coated with protein A. Thereafter, the rosetting and nonrosetting 
populations were cultured for 24 h  in the presence of 10 #g of Con A  and then assayed 
for PFC, which were almost exclusively in the rosetting fraction  (Fig.  7). Because this 
fraction  was  almost  completely comprised  of T  cells,  the  findings  again  support  the 
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FIG.  4.  PFC responses of BDF1 spleen cells cultured for 24 h with 10 tag/ml of Con A and assayed 
with unabsorbed (['T-F-I) or Ig column-absorbed (I-q) developing serum. The PFC response of cells 
cultured without Con A and developed with unabsorbed serum is also shown (1). 
Induction of T-PFC by Supernates  from Con A-activated Spleen Cells.  T  cells activated by 
mitogenic  doses  of Con  A  (1  btg) release  products,  some  of which  have  helper  or 
suppressor  activities  for  B  cells  (3).  It  was,  therefore,  of interest  to  determine  if 
products were also released which  influenced  the appearance of T-PFC.  The super- 
nates from cultures of BDF~ spleen cells cultured with  1.0/~g of Con A for 48 h  were 
absorbed with Sephadex G-50 to remove residual Con A, concentrated to 0.2 initial 
volume, and added to fresh spleen cell cultures for 48 h, after which the number ofT- 
PFC were determined  (Fig.  8).  The Con A  supernate did,  indeed,  induce  a  T-PFC 
response  as  compared  to  supernates  from  control  cultures  without  Con  A  and  to 
positive controls  directly  induced  with  Con  A.  As  already  indicated,  this  activity 
cannot be a result of residual Con A in the absorbed supernates because the amount 
of Con A  required  to induce a  substantial T-PFC response (at  least  2/xg)  is higher 
than that used to induce the supernate (1 #g) and, further, the supernate was absorbed 
with Sephadex G-50 to remove residual Con A. The absorbed supernate was unable 
to  induce  a  mitogenic  response  in  high  density  spleen  cell  cultures,  which  are 
responsive to  1-/xg doses of Con  A.  We tentatively conclude,  therefore,  that  spleen 
cells  (probably  T  cells)  activated  by  Con  A  release  product(s)  which  induce  the 
formation of T-PFC. 
Discussion 
The results presented here establish that a hemolytic plaque assay can be adapted 
to the detection of activated T  lymphocytes secreting soluble products. The products 
detected by the assay, as used in these studies, are undefined because the developing t~ 
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Fig. 5.  PFC response of enriched T cells from BDF] mice cultured for 10 d with 2 (I-q) or 20 
(l'T-l-I)  p.g/ml of Con A. Complement was added 1 (A) or 18 (B) h after plaquing. 
antiserum  was  raised  against  a  crude  supernate  of Con  A-activated  spleen  cells. 
However, the ground work has been laid whereby antisera specific for T-cell products 
with  defined  activity can  be used  to  detect  and  enumerate  the  cells  secreting  the 
particular  mediator  in  question.  Thus,  the  activities  of individual  T  cells  can  be 
explored in a  manner analogous to the study of B cells during the past decade or so 
since  the  development  of the  Jerne  plaque  assay.  This  technique  has  enormous 
potential,  for example,  for the  clonal  analysis  of lymphokine production.  What  is 
needed  for this  purpose are  monospecific  (preferably monoclonal)  antisera  against 
defined lymphokines which can be used as developing reagents in the plaque assay. 
This hemolytic plaque assay for T  cells is technically simpler and potentially much 
more  versatile  than  the  viral  plaque  assay  for  detecting  antigen-activated  T  cells 
described some years ago (10).  That assay only detected cells releasing viral particles, 
a property of activated, viral-infected cells, rather than cells releasing specific products 
of immunological interest. 
The evidence that the PFC  in this assay are T  cells rests on immunofluorescence 
staining for the Thy-1 marker, depletion of PFC by treatment with anti-Thy-1  and 
anti-Ly 2.2  sera and complement, their enrichment  by removing B cells on anti-Ig- 
coated plates, their induction  by selective T  cell, but  not  by B  cell, mitogens, their 









Fie;.  6.  PFC responses of spleen cells from BALB/c mice sensitized to L929 cells. Target cell 
adherent population (l-J--l-I);  target cell nonadherent population (~); spleen cells from immunized 
mice (m); L929 cells alone (1"7). 
in  a  selected  population  of killer  cells.  In  addition,  the  possibility  that  the  assay 
detected  immunoglobulin-secreting cells was  excluded  by the  strict  dependency  of 
plaque formation on the presence of developing serum and by the observation that 
absorption of the anti-supernatant serum with a polyvalent mouse Ig immunoadsorb- 
ent had no effect on the numbers of PFC. These results, therefore, synergize to form 
a compelling case for the assignment of PFC to the T-cell lineage. 
It is noteworthy that the plaques produced by T  cells using this technique differ in 
several respects from those produced by antibody-secreting cells. One difference is the 
time of incubation  required  for the development of plaques.  Whereas conventional 
protein  A  plaques  by B  cells  require  3-4  h  of incubation  for detection  (2),  T-cell 
plaques, when induced by high doses of mitogen, are fully developed within 45 min. 
On the other hand, induction of T-PFC by low concentrations of mitogen requires a 
much longer time of incubation.  Another distinctive characteristic of T  cell plaques 
was the apparent  relationship  of their size and morphology to the concentration  of 
the  developing  antiserum.  Thus,  rabbit  serum  diluted  1:2  produced  very  small, 
discrete plaques, whereas at dilution~ of 1:5 or 1:6 much larger plaques formed, which 
in  some  instances  reached  a  diameter  of 3  mm.  These  larger  plaques  contained 
unlysed erythrocytes near their centers, assuming a ring-like or sombrero appearance. 
This effect may be a result of an excess of antigen (secreted product) in the immediate 
vicinity  of the  secreting  cell.  The  plaque  size  variation  as  an  inverse  function  of 
antibody concentration is readily understandable in terms of antigen/antibody ratios. PRIMI, LEWIS, AND GOODMAN 








Fie.  7.  Spleen cells from BDF~ mice were rosetted with SRBC coated with lg from anti-Con A 
supernatant  developing serum. The rosetting (1"1) and  nonrosetting (U)  populations, as well as 
unfractionated spleen cells ([W]-]) were then cultured for 24 h with 10 ~g/ml of Con A, after which 
the numbers of PFC were assayed. The background response of spleen cells cultured without Con 
A (m) is also shown. 
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At  higher  concentrations  of antibody  in  the  plaquing  medium,  secreted  antigen  is 
completely bound over a  shorter radius of diffusion, giving rise to smaller plaques. 
Regarding the mechanism of plaque  formation, two possibilities  exist.  The first is 
that activated T  cells actively release products which bind to antibody on protein A 
SRBC and induce lysis in the presence of complement. The second possibility is that 
anti-supernatant  antibodies bind to T  cells and in the presence of complement cause 
their lysis; subsequent  passive release of cellular products in a second step could form 
complexes with antibody on SRBC, causing plaque formation. We favor the former 
hypothesis because  the  observation  that  induction  of PFC  by low doses of mitogen 
requires  Longer times  of incubation  as compared with  high  doses is  not compatible 
with a  passive mode of secretion as a  result of cell lysis. 
Although  the  experiments  described  in  this  paper  were  primarily  designed  to 
establish  the T-cell nature  of the  PFC,  they also offer important  information  about 
the cells in question. The most remarkable finding was that antibody to the supernate 
of Con  A-induced  spleen  cells  reacted  with  the  surfaces  of T  cells  which  formed 
plaques.  The implication  of this  finding  is  that  T  cells  express  on  their surface  the 
product(s) which they are programmed to secrete. This has a very close parallel in the 
expression of surface Ig by B cells, and has far-reaching implications because antibody 
to specific T-cell products may be used to isolate the cells making the products.  The 
fact  that  different  doses  of mitogen  induced  secretion  at  different  rates  seems  to 
suggest a  functional duality of mitogens with respect to cell activation and secretion. 998 
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FIG. 8.  Spleen cells from BDF1 mice were cultured for 48 h with 0.05 ml of BSS (F-l), 10 #g/ml of 
Con A (J'T'~), or 0.05 ml of Con A-induced culture supernate  (I), after which PFC were assayed. 
However, whether the products detected by the assay after activation with different 
doses of mitogen differ only in rates of secretion remains, at the moment, an important 
but  undecided  question.  The only safe conclusion  that  can  be  made  at  the present 
time is that to obtain maximum sensitivity using this assay, it is necessary to run the 
plaque assay for at least  15 h  before adding complement. 
Another  point  of interest  was  the  observation  that  supernates  from  spleen  cells 
cultured  in  the  presence  o'f Con  A  supernate  (from  which  residual  Con  A  was 
subsequently removed)  induced T-PFC responses, which may have important impli- 
cations for our understanding of immune regulation, because it is consistent with the 
hypothesis that the immune system may be self-perpetuating. PRIMI, LEWIS, AND GOODMAN  999 
Finally, the high efficiency of plaque formation (10%) by allogeneically induced 
cytotoxic cells which can be isolated by adherence to targets seems to suggest that our 
developing  serum  contains  significant  activity  against  products  released  by  this 
functional population of T cells. 
It is apparent that the work described here represents only a beginning. However, 
it clearly offers new possibilities for the analysis ofT lymphocytes and their products. 
Defined T-cell products and monospecific antisera can now be almost routinely raised 
by using hybridoma technology. Experiments aimed at the detection of cells which 
secrete  a defined product are in progress  in our laboratory and encouraging results 
have been obtained in the study of mitogen-activated human peripheral blood T 
lymphocytes which form plaques with rabbit  antiserum to highly purified human 
lymphotoxin. 
Summary 
In an earlier report, it was shown that murine spleen cells cultured with concana- 
valin  A  (Con  A)  released  into  the  culture  supernatants  helper  and  suppressor 
substances for antibody production. The present communication describes  the pro- 
duction of rabbit  antisera against culture supernates from Con A-activated spleen 
cells and their use in a plaque assay for mitogen-activated T cells. The plaque assay, 
utilizing SRBC to which Staphylococcal protein A had been coupled, the developing 
anti-supernatant antiserum and guinea pig complement, readily detected secreting T 
cells. The T-cell nature of the plaque-forming cells (PFC) was established principally 
by the following:  (a) the majority of lymphocytes in the centers of plaques were Thy- 
l-positive by fluroescence;  (b) spleen cells depleted of B cells by incubation in plastic 
dishes coated with rabbit anti-mouse Ig antibody gave greatly enriched PFC responses; 
(c)  anti-Thy-1 and anti-Lyt-2.2 treatment of spleen cells almost completely depleted 
PFC;  (d) T-cell  mitogens (Con A and phytohemagglutinin) but not B-cell mitogens 
(lipopolysaccharides)  induced PFC responses;  (e) T cells maintained in culture for 10 
d with Con A and T-cell growth factor yielded PFC. 
Kinetic and  dose  response  studies  showed  that  high  doses  of mitogen  induced 
rapidly appearing T-PFC and the responses peaked at day 1-2 of  culture. Lower doses 
of mitogen-induced PFC required longer periods of incubation for detection, indicat- 
ing that cell activation and secretion  may be different dose-dependent activities of 
mitogens. Another noteworthy finding was that the antiserum reacted with surface 
antigens of T-PFC, indicating that secreted products are expressed on the membranes 
ofT cells, offering the possibility of isolating populations of  cells with specific secretory 
potential. Although the precise nature of the T-cell products detected by the antiserum 
used in this assay are unresolved,  10% of the target-cell-adherent population from 
spleen cells of BALB/c mice sensitized  to L929 cells formed plaques. This suggests 
that the antiserum has significant activity against the products of cytotoxic T cells, a 
finding which accords with the activity of anti-Lyt 2.2 serum against mitogen-induced 
T-PFC. The method clearly offers new possibilities for the analysis ofT cells and their 
products  and  should  provide  an  important  approach  to  the  clonal  analysis of 
lymphokine production. 
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